• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1981年至1995年德国下弗兰肯地区甲状腺癌发病率和预后的变化趋势

Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995.

作者信息

Farahati Jamshid, Geling Markus, Mäder Uwe, Mörtl Markus, Luster Markus, Müller Justus G, Flentje Michael, Reiners Christoph

机构信息

Department of Nuclear Medicine, University of Wuerzburg, Germany.

出版信息

Thyroid. 2004 Feb;14(2):141-7. doi: 10.1089/105072504322880382.

DOI:10.1089/105072504322880382
PMID:15068629
Abstract

BACKGROUND

A population-based registry (PBR) in Lower Frankonia in southern Germany was conducted to evaluate the changes of incidence and prognosis of thyroid carcinoma (TC) in this area.

METHODS

The study comprised 476 patients with differentiated thyroid carcinoma (DTC) from Lower Franconia (1.3 x 10(6) inhabitants) registered between 1981 and 1995 at the Regional Tumor Center. The incidence was assessed with respect to gender, age, histology, tumor stage, lymph node involvement and distant metastases in 5-year intervals (1981-1985, 1986-1990, and 1991-1995).

RESULTS

An increasing rate of papillary thyroid carcinoma PTC and a decreasing rate of follicular thyroid carcinoma (FTC) were observed over the three time periods (1981-1985, 1986-1990, and 1991-1995). The overall incidence revealed no significant change with time for both females from 3.22 to 3.25 and 3.73 and males (1.07 to 1.54 and 1.69) between the three time periods. There was a significant improvement in outcome of patients with DTC with respect to life expectancy.

CONCLUSIONS

Iodine prophylaxis does influence the distribution of the histologic types of thyroid cancer and leads to an increase in the ratio of papillary versus follicular carcinoma. Our study supports the hypothesis that the benefits of correcting iodine deficency outweigh the risks of iodine supplementation.

摘要

背景

在德国南部下弗兰肯地区开展了一项基于人群的登记研究(PBR),以评估该地区甲状腺癌(TC)的发病率和预后变化。

方法

该研究纳入了1981年至1995年间在地区肿瘤中心登记的476例来自下弗兰肯地区(130万居民)的分化型甲状腺癌(DTC)患者。按性别、年龄、组织学类型、肿瘤分期、淋巴结受累情况和远处转移情况,以5年为间隔(1981 - 1985年、1986 - 1990年和1991 - 1995年)评估发病率。

结果

在三个时间段(1981 - 1985年、1986 - 1990年和1991 - 1995年)观察到乳头状甲状腺癌(PTC)发病率上升,滤泡状甲状腺癌(FTC)发病率下降。三个时间段内,女性总体发病率从3.22到3.25以及3.73,男性从1.07到1.54以及1.69,随时间均无显著变化。DTC患者的预期寿命结局有显著改善。

结论

碘预防措施确实会影响甲状腺癌组织学类型的分布,并导致乳头状癌与滤泡状癌的比例增加。我们的研究支持以下假设,即纠正碘缺乏的益处超过补充碘的风险。

相似文献

1
Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995.1981年至1995年德国下弗兰肯地区甲状腺癌发病率和预后的变化趋势
Thyroid. 2004 Feb;14(2):141-7. doi: 10.1089/105072504322880382.
2
The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency.塔斯马尼亚岛甲状腺癌发病率和谱在从碘充足向碘缺乏转变期间(1978 - 1998年)的变化
J Clin Endocrinol Metab. 2000 Apr;85(4):1513-7. doi: 10.1210/jcem.85.4.6554.
3
Changing trends in incidence and mortality of thyroid cancer in Scotland.苏格兰甲状腺癌发病率和死亡率的变化趋势
Clin Endocrinol (Oxf). 2005 Feb;62(2):156-62. doi: 10.1111/j.1365-2265.2004.02187.x.
4
[Epidemiology of thyroid cancer in Poland].[波兰甲状腺癌的流行病学]
Wiad Lek. 2001;54 Suppl 1:106-16.
5
Thyroid cancer in Vaud, Switzerland: an update.
Thyroid. 2002 Feb;12(2):163-8. doi: 10.1089/105072502753522400.
6
Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.希腊 1991 年至 2006 年间甲状腺切除术患者甲状腺乳头状癌检出率增高。
Anticancer Res. 2009 Dec;29(12):5163-9.
7
Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence.奥地利克恩顿州甲状腺癌的描述性流行病学:1984 - 2001年。自1990年以来食盐普遍加碘情况下734例病例的组织病理学特征及肿瘤分类:基于人群的甲状腺癌发病率年龄分层分析。
Thyroid. 2004 Apr;14(4):277-86. doi: 10.1089/105072504323030933.
8
Global variation in the pattern of differentiated thyroid cancer.全球分化型甲状腺癌的模式变化。
Am J Surg. 2010 Oct;200(4):462-6. doi: 10.1016/j.amjsurg.2010.03.009.
9
Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.甲状腺癌:中国东南部浙江省的发病、死亡趋势和临床病理特征。
BMC Cancer. 2018 Mar 15;18(1):291. doi: 10.1186/s12885-018-4081-7.
10
Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.在瑞典的一个县中分化型甲状腺癌——长期结果和生活质量。
Acta Oncol. 2010 May;49(4):454-9. doi: 10.3109/02841860903544600.

引用本文的文献

1
Major Vault Protein (MVP) Associated With Mutation Is an Immune Microenvironment-Related Biomarker Promoting the Progression of Papillary Thyroid Cancer MAPK/ERK and PI3K/AKT Pathways.与突变相关的主要穹窿蛋白(MVP)是一种促进甲状腺乳头状癌进展的免疫微环境相关生物标志物,涉及MAPK/ERK和PI3K/AKT信号通路。
Front Cell Dev Biol. 2022 Mar 31;9:688370. doi: 10.3389/fcell.2021.688370. eCollection 2021.
2
T-Box Transcription Factor 22 Is an Immune Microenvironment-Related Biomarker Associated With the Mutation in Papillary Thyroid Carcinoma.T 盒转录因子 22 是一种与甲状腺乳头状癌突变相关的免疫微环境相关生物标志物。
Front Cell Dev Biol. 2020 Dec 17;8:590898. doi: 10.3389/fcell.2020.590898. eCollection 2020.
3
Association between Hashimoto's Thyroiditis and Thyroid Cancer in 64,628 Patients.
64628例患者中桥本甲状腺炎与甲状腺癌的关联
Front Oncol. 2017 Apr 10;7:53. doi: 10.3389/fonc.2017.00053. eCollection 2017.
4
Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features.具有乳头状核特征的非浸润性滤泡性甲状腺肿瘤和浸润性滤泡型甲状腺乳头状癌的分子相关性和淋巴结转移率:严格标准区分具有乳头状核特征的非浸润性滤泡性甲状腺肿瘤的影响。
Mod Pathol. 2017 Jun;30(6):810-825. doi: 10.1038/modpathol.2017.9. Epub 2017 Mar 10.
5
Molecular genetics of thyroid cancer.甲状腺癌的分子遗传学
Genet Res (Camb). 2016 May 13;98:e7. doi: 10.1017/S0016672316000057.
6
Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.碘摄入作为甲状腺癌的一个风险因素:对动物和人体研究的全面综述。
Thyroid Res. 2015 Jun 18;8:8. doi: 10.1186/s13044-015-0020-8. eCollection 2015.
7
Evolution of differentiated thyroid cancer: a decade of thyroidectomies in a single institution.分化型甲状腺癌的演变:单中心十年甲状腺切除术经验。
Eur Thyroid J. 2014 Sep;3(3):197-201. doi: 10.1159/000365416. Epub 2014 Aug 29.
8
The geographical pattern of thyroid cancer mortality between 1980 and 2009 in Italy.1980 年至 2009 年意大利甲状腺癌死亡率的地理分布模式。
Thyroid. 2013 Dec;23(12):1609-18. doi: 10.1089/thy.2013.0088. Epub 2013 Nov 6.
9
Undifferentiated (anaplastic) thyroid carcinoma and iodine intake in Salta, Argentina.阿根廷萨尔塔的未分化(间变性)甲状腺癌与碘摄入量。
Endocr Pathol. 2013 Sep;24(3):125-31. doi: 10.1007/s12022-013-9248-9.
10
Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.韩国过去四十年甲状腺癌临床病理特征和结局的变化。
Thyroid. 2013 Jul;23(7):797-804. doi: 10.1089/thy.2012.0329. Epub 2013 Jun 21.